Secoya Technologies raised €1M to commercialize its next-gen microfluidic equipment

February 22, 2023 11:00 am

We are delighted to announce the completion of our fundraising for an amount of €1million.

Bertrand Loriers, CEO commented: “This is a new milestone for Secoya. It will allow us to move to a new level of growth while we have a better knowledge of our customers and potential markets. These resources will indeed be allocated in a relevant way to our commercial deployment and to the operational reinforcement required to support our development. We seize the opportunity to thank our shareholders for trusting us.”

With a board of industry veterans, including former Delphi Genetics CEO Cédric Szpirer, Univercells co-founder Jose Castillo, Jean-Marie Solvay, and Stéphanie Hoffmann-Gendebien, Secoya already counts several major pharma companies among its clients in Europe and is expanding to the US.

Read the full article (in French): https://www.lecho.be/entreprises/pharma-biotechnologie/secoya-revisite-les-procedes-de-production-en-biopharma/10448380.html